Cell and gene therapies gain momentum in Basel
Companies specializing in the research and development of innovative cell and gene therapies continue to…
Companies specializing in the research and development of innovative cell and gene therapies continue to…
STALICLA SA, a clinical-stage biotech company advancing the first precision neurobiology platform for patients with…
Novartis Pharmaceuticals UK has announced that Xim, creators of Lifelight, and PocDoc are the successful…
Allarity Therapeutics, after meeting with the US Food and Drug Administration (FDA), has decided a…
After decades of neglect from big pharma, radiopharmaceuticals are generating major oncology deals globally. This…
Novartis Pharmaceuticals UK has launched the Novartis Biome UK Heart Health Catalyst 2022, in a…
CAR-T therapy has been hailed as a cure for cancer, but what really is this…
UK rapid diagnostics company Mologic will convert into a social enterprise after being acquired by…
While the EU saw rapid-fire approvals in the multiple sclerosis space last month, the innovations…
Update (19/05/2020): The gene therapy Zolgensma, developed by the big pharma Novartis and approved in…
Update (02/04/2020): The FDA has concluded an investigation into a data manipulation scandal surrounding the…
Novartis is to acquire The Medicines Company and its late-stage RNA interference drug designed to…